Removing the prostate does not directly remove a testosterone-producing organ, since testosterone comes from the testes, not the prostate. Yet the hormonal aftermath is far from straightforward. Research shows that roughly one in four or five men develop testosterone deficiency within the first month after radical prostatectomy, and a meaningful fraction remain deficient three months later. The reasons involve surgical stress, disrupted blood flow around the testes, and a recalibration of the brain-to-testes signaling system that can leave the body working harder just to maintain normal hormone levels.
The Short-Term Testosterone Drop
Within the first four weeks after radical prostatectomy, about 20 to 30 percent of men develop measurable testosterone deficiency. By day 90, the deficiency persists in roughly 37 percent of those affected.1PubMed. Etiology of testosterone deficiency after radical prostatectomy That is a significant chunk of men whose testosterone drops below normal thresholds after losing a gland that does not itself produce the hormone. Several mechanisms have been proposed for this, including disruption of blood vessels near the testes during surgery, temporary ischemia affecting testicular function, and broader neuroendocrine changes triggered by the operation. The evidence supporting each specific mechanism remains indirect, but the clinical pattern is well documented.
What surprises many men is that this early dip does not always resolve cleanly. Some men bounce back to their pre-surgical levels within a few months. Others settle into a state where their testosterone is technically in the normal range but their body is straining to keep it there, a situation that can produce symptoms even when blood work looks acceptable on paper.
Surgical Stress Itself Lowers Testosterone
Part of the short-term testosterone drop after prostatectomy has nothing to do with the prostate specifically. Any major surgery performed under general anesthesia temporarily suppresses testosterone production. Research on men undergoing various types of operations found that testosterone levels fell significantly during and immediately after both moderate and major surgery. After moderate procedures, levels began recovering by around the sixth day. After major surgery, the suppression lasted at least six days and correlated with the severity of the operation.2Acta Endocrinologica. Plasma Testosterone Levels Following Surgical Stress in Male Patients A separate study confirmed that the rate of testosterone decline tracked with how invasive the procedure was, with general anesthesia alone contributing to the suppression.3PubMed. Effects of general anaesthesia and severity of surgical stress on serum LH and testosterone in males
Radical prostatectomy is a major pelvic surgery involving substantial tissue dissection, nerve-sparing maneuvers, and reconstruction of the urinary tract. It sits firmly in the “major surgery” category for hormonal stress purposes. So when a man’s testosterone drops in the first week or two after the operation, some of that decline is simply what happens after any large operation. The question that matters clinically is what happens after the surgical stress response fades.
The Longer-Term Hormonal Shift
Once you look beyond the immediate postoperative period, the picture gets more nuanced and, frankly, somewhat contradictory depending on which study you read. One study that followed men for 12 months after radical prostatectomy found that the pituitary hormones LH and FSH rose substantially, while total testosterone edged up only modestly, from about 3.9 to 4.4 ng/mL, a change that was not statistically significant. Men who had TURP (a less invasive prostate procedure) or who were simply observed showed no hormonal changes at all over the same period.4PubMed. Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis That comparison is telling: the hormonal disruption appears to be specific to radical prostatectomy rather than just a consequence of any prostate procedure.
Other research, however, found that testosterone and free testosterone actually increased significantly after prostatectomy.5PubMed. Influence of radical prostatectomy on serum hormone levels The likely explanation for these differing results involves the wide range of pre-surgical testosterone levels among prostate cancer patients, differences in how far out from surgery measurements were taken, and variation in patient age and health. The broad pattern across studies is that the pituitary consistently ramps up its signaling to the testes after prostatectomy, but the degree to which the testes respond varies from man to man.
Why the Pituitary Works Harder After Prostatectomy
The brain’s pituitary gland controls testosterone production by releasing LH and FSH, which tell the testes to make hormones. After radical prostatectomy, both LH and FSH rise sharply. One longitudinal study found these increases were statistically significant at both one and three months after surgery.6PubMed Central. Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study Another study documented a 53 percent jump in LH and a 21 percent jump in FSH after the procedure.7PubMed. Radical prostatectomy: influence on serum and urinary androgen levels
This pattern is called compensated hypogonadism: the pituitary is shouting louder at the testes just to keep testosterone near its previous level. In one study, researchers described the state at three months post-surgery as “compensated hypergonadotropic hypogonadism,” meaning that testosterone was maintained but only because the pituitary was working overtime.6PubMed Central. Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study The normal feedback loop between LH and testosterone was disrupted at one month but began recovering by three months, with LH levels at one month predicting where testosterone would land at three months.
For a man reading his lab results, this matters practically. His total testosterone might look normal on a blood test, but if LH and FSH are elevated, his endocrine system is under strain. That compensatory state can be fragile. As men age and testicular reserve naturally declines, a system already running at higher effort may not keep up, potentially tipping into outright deficiency later.
What Happens to DHT
The prostate is a major consumer of dihydrotestosterone, a more potent form of testosterone that the body converts from regular testosterone. After prostatectomy, DHT levels in the blood drop significantly. One study found a statistically significant decrease in serum DHT after radical prostatectomy, even as testosterone and free testosterone rose.5PubMed. Influence of radical prostatectomy on serum hormone levels Another study measured the DHT decline at about 13 percent.7PubMed. Radical prostatectomy: influence on serum and urinary androgen levels
This seems intuitive: remove the prostate, lose its contribution to blood DHT. But the reality is more interesting. Research comparing men with and without a prostate who were given identical testosterone doses found that the prostate is not actually a major contributor to circulating DHT levels.8The Journal of Clinical Endocrinology & Metabolism. Estimating the Contribution of the Prostate to Blood Dihydrotestosterone DHT is produced throughout the body, including in the skin, liver, and other tissues. So the post-surgical DHT decline likely has less to do with losing the prostate’s own DHT production and more to do with the broader hormonal upheaval in the weeks and months after surgery. The clinical significance of modestly lower DHT for most men is unclear, since DHT’s most visible role, driving hair loss and prostate growth, becomes less relevant once the prostate is gone.
Many Men Already Have Low Testosterone Before Surgery
A crucial piece of context that often gets missed in conversations about post-surgical testosterone: a substantial number of men diagnosed with prostate cancer already have low testosterone before they ever reach the operating room. Research has found that testosterone levels decrease as cancer aggressiveness increases, with men who have more advanced disease tending to have the lowest pre-surgical levels.9PubMed Central. Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer Men with low testosterone at diagnosis faced substantially higher odds of having aggressive or metastatic disease compared to men with normal levels.
This means that when a man tests low for testosterone a few months after prostatectomy, the surgery may not be entirely responsible. He may have entered the operating room with levels that were already declining, and the surgical stress simply pushed him below the threshold where symptoms become noticeable. This distinction matters for treatment decisions: a man whose testosterone was borderline before surgery is in a different situation from one whose levels were robust and then cratered afterward.
It also complicates how you interpret the statistics on post-surgical testosterone deficiency. If 20 to 30 percent of men develop deficiency in the first month, some fraction of those men were probably headed toward deficiency regardless. Separating surgery-caused decline from cancer-associated decline from normal aging decline is genuinely difficult, and most studies do not fully disentangle these threads.
Symptoms That Overlap With Low Testosterone
After radical prostatectomy, men commonly report low libido, erectile dysfunction, hot flashes, fatigue, reduced physical function, and limited mobility. Even with a bilateral nerve-sparing approach designed to preserve sexual function, more than half of men develop some degree of sexual dysfunction after surgery.10PubMed Central. Testosterone replacement in prostate cancer survivors with testosterone deficiency: study protocol of a randomized controlled trial These symptoms track closely with what you would expect from testosterone deficiency, which creates a clinical puzzle: are these symptoms caused by nerve damage during surgery, by psychological adjustment to cancer treatment, by hormonal changes, or by some combination?
The answer, in most cases, is all of the above. Nerve injury accounts for a large share of post-surgical erectile dysfunction, and no amount of testosterone will repair a severed nerve. But androgen deficiency makes recovery harder. A man whose testosterone is low heals more slowly, has less energy for rehabilitation, and may struggle with the motivational and mood effects of hypogonadism on top of everything else. This is why some clinicians have begun paying closer attention to post-surgical testosterone levels rather than assuming that all recovery issues are purely surgical or neurological.
Preoperative testosterone levels also appear to influence outcomes. One study found that higher testosterone before surgery was an independent predictor of better potency recovery afterward.6PubMed Central. Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study Men going into surgery with healthier hormonal baselines tended to fare better on the other side, suggesting that testosterone status matters both before and after the operation.
Testosterone Replacement After Prostate Cancer Surgery
For decades, testosterone replacement therapy was considered off-limits for prostate cancer survivors. The reasoning was simple and widely believed: testosterone fuels prostate cancer, so giving testosterone to a man who just had cancer removed would be reckless. This concern traces back to early observations from the 1940s showing that castration (which eliminates nearly all testosterone) caused prostate tumors to shrink, while administering testosterone made them grow.
The modern evidence has substantially complicated that picture. A study of men who received testosterone therapy after radical prostatectomy for organ-confined prostate cancer found no significant increase in cancer recurrence. The probability of biochemical recurrence at five years was less than 2 percent in both the treated and untreated groups.11PubMed Central. Testosterone Therapy in Men After Radical Prostatectomy for Low-Intermediate Organ-Confined Prostate Cancer A larger study with adjusted statistical models found no differences in biochemical recurrence, cancer-specific death, or overall death between men who received testosterone therapy after definitive treatment and those who did not.12PubMed Central. Testosterone Therapy Does Not Increase the Risks of Prostate Cancer Recurrence or Death After Definitive Treatment for Localized Disease
These findings do not mean testosterone replacement is universally safe for all prostate cancer survivors. The studies primarily involve men with low-to-intermediate risk, organ-confined cancer who had complete surgical removal. Men with high-risk disease, positive margins, or detectable PSA after surgery are in a different risk category, and the data for those groups is thinner. But for men with favorable pathology who develop bothersome testosterone deficiency symptoms after prostatectomy, the blanket prohibition that characterized earlier decades of urology practice is giving way to a more individualized risk assessment.
How Surgical Technique Affects Hormonal Recovery
Not all radical prostatectomies are identical, and the approach used may influence hormonal outcomes. Robot-assisted surgery has become the dominant technique in many countries, and research comparing robot-assisted and traditional open procedures has identified several factors that predict functional recovery. In one study, younger age and the robotic approach were both independent predictors of better potency recovery, alongside higher preoperative testosterone.
The connection between surgical technique and hormone levels is mostly indirect. A more precise dissection may cause less collateral vascular and nerve damage in the pelvis, which in turn could reduce the ischemic insult to the testes that some researchers believe contributes to post-surgical testosterone deficiency. This remains speculative, since no trial has directly compared testosterone outcomes between surgical approaches while controlling for all other variables. But it aligns with the broader principle that less tissue trauma means less hormonal disruption.
For men facing the decision about surgical approach, testosterone outcomes are rarely the primary consideration. Continence and sexual function dominate those conversations. Still, understanding that the hormonal effects of surgery are not fixed or predetermined can be reassuring. The body’s endocrine system is resilient, and for the majority of men, the acute hormonal disruption after prostatectomy is just that, acute. The pituitary ramps up, the testes respond, and most men reach a new hormonal equilibrium within a few months. Whether that equilibrium is adequate depends on where they started, how their surgery went, and how much reserve their testes still have.
Muscle Mass, Body Composition, and Post-Surgical Testosterone
Testosterone does not operate in isolation from the rest of the body. After radical prostatectomy, a man’s overall physical condition influences and is influenced by his hormonal status. Research has found that muscle mass, as measured by the psoas muscle index, correlates positively with bioavailable testosterone in prostate cancer patients who underwent surgery.13PubMed. Association of Muscle Mass with Survival after Radical Prostatectomy in Patients with Prostate Cancer Men with more muscle tended to have higher levels of the testosterone fraction that the body can actually use.
This creates a feedback loop that can work for or against recovery. A man who maintains physical activity and muscle mass after surgery is more likely to preserve adequate testosterone levels, which in turn supports further muscle maintenance, energy, and overall well-being. A man who becomes sedentary after surgery, whether from pain, incontinence, fatigue, or depression, risks entering a cycle where declining activity leads to muscle loss, which is associated with lower bioavailable testosterone, which makes it harder to return to activity. None of this is unique to prostatectomy patients; it applies to aging men generally. But the post-surgical hormonal disruption can accelerate the process in a way that makes early rehabilitation and physical activity particularly valuable during recovery.